Omkar Pharmachem Limited (BOM:532167)
India flag India · Delayed Price · Currency is INR
11.65
-0.61 (-4.98%)
At close: Aug 21, 2026

Omkar Pharmachem Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
4.24.655.45.45.45.4
Revenue Growth
-22.22%-13.89%0%0%0%100.00%
Gross Profit
2.092.563.793.84.013.65
Operating Income
1.121.582.852.783.082.67
Net Income
0.851.222.011.891.981.83
Earnings Per Share
0.08-0.200.190.200.18
EPS Growth
-52.35%-6.24%-4.40%8.97%-18.02%

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
2.172.171.090.721.332.11
Total Debt
--1.193.036.219.3
Net Cash (Debt)
2.172.17-0.09-2.32-4.89-7.18
Net Cash Growth
------
Net Cash Per Share
0.22--0.01-0.23-0.48-0.71

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-2.282.442.962.762.03
Capital Expenditures
---0.04-0.09--0.07
Free Cash Flow
-2.282.42.862.761.96
Free Cash Flow Growth
--4.63%-16.35%3.77%40.77%775.00%

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
49.83%55.14%70.24%70.28%74.28%67.57%
Operating Margin
26.60%33.87%52.76%51.56%57.07%49.41%
Pretax Margin
27.86%35.01%50.00%46.81%48.98%38.98%
Profit Margin
20.29%26.19%37.20%35.02%36.63%33.91%
FCF Margin
-49.12%44.35%53.02%51.09%36.30%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
138.12244.23150.58119.88127.45112.35
P/FCF Ratio
51.43130.24126.3179.1891.37104.96
PS Ratio
27.9763.9756.0241.9846.6938.10